Year: 2022
Type: article
Abstract: The Lewy Body Dementia Association (LBDA) held a virtual event, the LBDA Biofluid/Tissue Biomarker Symposium, on January 25, 2021, to present advances in biomarkers for Lewy body dementia (LBD), which includes dementia with Lewy bodies (DLBs) and Parkinson's disease dementia (PDD). The meeting featured eight internationally known scientists from Europe and the United States and attracted over 200 scientists and physicians from academic centers, the National Institutes of Health, and the pharmaceutical industry. Methods for confirming and quantifying the presence of Lewy body and Alzheimer's pathology and novel biomarkers were discussed.
Source: Frontiers in Neurology
Authors: Gregory D. Scott, Moriah R. Arnold, Thomas G. Beach, Christopher H. Gibbons, Anumantha G. Kanthasamy, Russell M. Lebovitz, Afina W. Lemstra, Leslie M. Shaw, Charlotte E. Teunissen, Henrik Zetterberg, Angela S. Taylor, Todd C. Graham, Bradley F. Boeve, Stephen N. Gomperts, Neill R. Graff-Radford, Charbel E.-H. Moussa, Kathleen L. Poston, Liana S. Rosenthal, Marwan N. Sabbagh, Ryan R. Walsh, Miriam T. Weber, Melissa J. Armstrong, Jee A. Bang, Andrea C. Bozoki, Kimiko Domoto-Reilly, John E. Duda, Jori E. Fleisher, Douglas R. Galasko, James E. Galvin, Jennifer G. Goldman, Samantha K. Holden, Lawrence S. Honig, Daniel E. Huddleston, James B. Leverenz, Irene Litvan, Carol A. Manning, Karen S. Marder, Alexander Y. Pantelyat, Victoria S. Pelak, Douglas W. Scharre, Sharon J. Sha, Holly A. Shill, Mari Zoltan, Joseph F. Quinn, David J. Irwin
Institutions: Oregon Health & Science University, Portland VA Medical Center, Banner Sun Health Research Institute, Beth Israel Deaconess Medical Center, Harvard University, University of Georgia, Iowa State University, Amprion (United States), Amsterdam Neuroscience, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, University of Pennsylvania, Sahlgrenska University Hospital, UK Dementia Research Institute, UCL Queen Square Institute of Neurology, University College London, University of Gothenburg, Lewy Body Dementia Association, Mayo Clinic, Massachusetts General Hospital, Mayo Clinic in Florida, Georgetown University Medical Center, Stanford University, Johns Hopkins University, Johns Hopkins Medicine, Barrow Neurological Institute, Lou Ruvo Brain Institute, Cleveland Clinic Lerner College of Medicine, University of Rochester Medicine, University of Rochester, University of Florida Health, University of Florida, University of North Carolina at Chapel Hill, University of Washington, Philadelphia VA Medical Center, Rush University Medical Center, Rush University, University of California San Diego, University of Miami, University of Miami Health System, Northwestern University, Shirley Ryan AbilityLab, University of Colorado Anschutz, University of Colorado Denver, Columbia University Irving Medical Center, Emory University, Weill Cornell Medicine, Cleveland Clinic, University of Virginia, The Ohio State University Wexner Medical Center, The Ohio State University, University of Pennsylvania Health System
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,950
Funders: U.S. Department of Veterans Affairs, Michael J. Fox Foundation for Parkinson's Research, Alzheimer's Drug Discovery Foundation, Sanofi, American Academy of Neurology, Biogen, Florida Department of Health, University of Pennsylvania, Emory University, Johns Hopkins University, CurePSP, Davis Phinney Foundation, Little Family Foundation, Demensförbundet, Parkinson's Foundation, Cognoptix, Denali Therapeutics, Lewy Body Dementia Association, Eisai, National Institutes of Health, Genentech, National Institute on Aging, National Institute of Neurological Disorders and Stroke
Awards: G1075639496, G1236162799, G1310852075, G1672092672, G1734067475, G1859882300, G2204888712, G234895681, G2622865600, G2957681590, G30524075, G3146424788, G333817976, G3373356737, G3676240031, G3870774570, G3919444319, G3929952641, G5534829898, G5635105673, G578486741, MRI Signatures of Neuromelanin and Iron Pathology in Parkinsonism, G6336656591, G6371410416, G6899163935, G7294583641, G753032722, G8019052532, G8196206454, G8221935348, Reaching the Most Vulnerable: A Novel Model of Care in Advanced Parkinson's Disease, G8931917679, G9000008846, G9000031905, G9000033698, G9000034532, G9000041203, G9000055340, G9000084068, G9000087139, G9000118926, G9000122335, G9000164485, G9000179483, G9000332211, University of Washington Alzheimer's Disease Research Center, Massachusetts Alzheimer's Disease Research Center (MADRC)
OpenAlex ID: W4220654530